×
About 3,155 results

ALLMedicine™ Hyperbilirubinemia Center

Research & Reviews  1,114 results

Effects of delayed cord clamping on neonatal hyperbilirubinemia in pre-gestational diab...
https://doi.org/10.1080/14767058.2021.1946785
The Journal of Maternal-fetal & Neonatal Medicine : the O... Bennett C, Munoz JL et. al.

Jul 30th, 2021 - To evaluate the effects of delayed cord clamping on neonatal hyperbilirubinemia in infants born to patients diagnosed with pre-gestational diabetes (type I or type II). In January 2016, our institution implemented an organization-wide thirty-secon...

Pattern And Prevalence of Liver Involvement in Pediatric Acute Lymphoblastic and Myeloi...
https://doi.org/10.1097/MPG.0000000000003243
Journal of Pediatric Gastroenterology and Nutrition; Sandart A, Harila-Saari A et. al.

Jul 23rd, 2021 - The prevalence and significance of liver involvement at diagnosis was studied in pediatric acute lymphoblastic (ALL) and myeloid leukemia (AML). A population based cohort of 122 pre B-ALL, 22 T-ALL and 45 AML patients was formed from the Nordic So...

The incidence, risk factors, and prognosis of postoperative hyperbilirubinemia after ca...
https://doi.org/10.21037/apm-21-410
Annals of Palliative Medicine; Chen X, Bai M et. al.

Jul 16th, 2021 - The purpose of the present systematic review was to evaluate the incidence, risk factors, and outcome of hyperbilirubinemia after cardiac surgery. The Population, Interventions, Comparators, Outcomes, and Study design (PICOS) framework was employe...

Cephalocaudal progression of neonatal jaundice assessed by transcutaneous bilirubin mea...
https://doi.org/10.1016/j.earlhumdev.2021.105418
Early Human Development; Kamphuis ASJ, Bekhof J

Jul 16th, 2021 - The cephalocaudal progression in neonatal jaundice is a well-known phenomenon. Since transcutaneous bilirubin measurements (TcB) are increasingly applied, for which different body site can be used, we aimed to quantify the cephalocaudal progressio...

Direct Hyperbilirubinemia as a Predictor of Mortality in Patients with Liver Cirrhosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283295
Gut and Liver; Lee CH, Kim IH

Jul 16th, 2021 - Direct Hyperbilirubinemia as a Predictor of Mortality in Patients with Liver Cirrhosis.|2021|Lee CH,Kim IH,|

see more →

Guidelines  3 results

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Ata...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785051
Clinical Pharmacology and Therapeutics; Gammal RS, Court MH et. al.

Sep 30th, 2015 - The antiretroviral protease inhibitor atazanavir inhibits hepatic uridine diphosphate glucuronosyltransferase (UGT) 1A1, thereby preventing the glucuronidation and elimination of bilirubin. Resultant indirect hyperbilirubinemia with jaundice can c...

Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or ...
https://doi.org/10.1542/peds.2011-1494
Pediatrics Bhutani VK, et. al.

Sep 29th, 2011 - To standardize the use of phototherapy consistent with the American Academy of Pediatrics clinical practice guideline for the management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Relevant literature was reviewed. P...

Universal screening for hyperbilirubinemia.
https://doi.org/10.1111/j.1751-486X.2010.01516.x
Nursing for Women's Health;

Feb 9th, 2010 - Universal screening for hyperbilirubinemia.|2010||blood,blood,diagnosis,standards,

see more →

Drugs  35 results see all →

Clinicaltrials.gov  42 results

Using the Electronic Health Record to Guide Management of Newborn Weight Loss
https://clinicaltrials.gov/ct2/show/NCT03655314

Mar 26th, 2020 - Weight loss is normal for healthy newborns in the first few days, especially for those exclusively breastfed, who may have low enteral intake for several days. Although most newborns tolerate this early period of weight loss well, those with prono...

Sonographic Evaluation of Fetal Growth in the Third Trimester of Low-risk Pregnancy: a Randomized Trial
https://clinicaltrials.gov/ct2/show/NCT03200665

Jan 21st, 2020 - The population to include in this study corresponds to the low-risk pregnant women with surveillance at the Prenatal Consultation or referenced by the Primary Care units to the Department of Obstetrics & Gynecology of Hospital de Santa Maria. The ...

Safety and Pharmacology of Stanate
https://clinicaltrials.gov/ct2/show/NCT00115544

Oct 15th, 2019 - The present study evaluated the relationship between Stanate® dose, drug safety, and efficacy in a non randomised sequential open label cohort design, in 55 patients. Subjects were term and near term infants at medium or high risk of hyperbilirubi...

Intrapartum Glucose and Insulin Compared to Glucose Alone in Diabetic Women
https://clinicaltrials.gov/ct2/show/NCT03273881

Aug 21st, 2019 - About 2 to 9% of pregnant women are diagnosed with gestational diabetes. Peripartum complications attributed to diabetes include: birth trauma, neonatal hypoglycemia and hyperinsulinemia and neonatal hyperbilirubinemia. The incidence of neonatal h...

Effect of Early Limited Formula on Total Serum Bilirubin Among Newborns With Hyperbilirubinemia
https://clinicaltrials.gov/ct2/show/NCT01330667

Nov 15th, 2018 - Inclusion criteria Healthy infants ≥ 35 weeks Neonates 36-96 hours old Exclusively breastfeeding TSB 0.1-3 mg/dl below AAP-recommended PT threshold TSB < 6 hours ago Mothers English-speaking or Spanish-speaking Outcome Measures Primary outcome: To...

see more →

News  67 results

New Model May Simplify Hyperbilirubinemia Risk Estimation
https://www.medscape.com/viewarticle/950085

Apr 29th, 2021 - NEW YORK (Reuters Health) - Researchers have developed a more precise and simpler method to determine when a newborn requires outpatient follow-up for jaundice. Their method had "excellent ability to predict postdischarge total serum bilirubin (TS...

EMA Green Light for Avapritinib for GIST, Acalabrutinib for CLL
https://www.medscape.com/viewarticle/934648

Jul 27th, 2020 - The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has given a thumbs up to two new oncology drugs.  The Committee has recommended granting conditional marketing authorization for avapritinib (Ayvakit, Bluepr...

EMA Green Light for Avapritinib for GIST, Acalabrutinib for CLL
https://www.staging.medscape.com/viewarticle/934648

Jul 27th, 2020 - The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has given a thumbs up to two new oncology drugs.  The Committee has recommended granting conditional marketing authorization for avapritinib (Ayvakit, Bluepr...

Fast Five Quiz: Sepsis Key Aspects
https://reference.staging.medscape.com/viewarticle/932124_5

Jun 17th, 2020 - Multiple clinical, laboratory, radiologic, and microbiological data are required for the diagnosis of sepsis and septic shock. Sepsis cannot be diagnosed on the basis of a single abnormality. However, the diagnosis is often made empirically at the...

Malpractice Case: Be Aware When Follow-up Requires Extra Steps
https://www.medscape.com/viewarticle/924898_1

Mar 2nd, 2020 - Some communications among a patient's healthcare team may not be as direct as one would prefer, but they may still trigger a duty on the recipient to follow up. Dr P, a general pediatrician, was called to attend a vaginal delivery of a newborn wit...

see more →

Patient Education  1 results see all →